Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigabatrin for cocaine dependence in parolees
NCT00527683Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Apr 2007
- Primary completion
- Nov 2007
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vigabatrin in cocaine dependence, sponsored by NYU Langone Health. Primary endpoint: Three consecutive weeks of negative urine tests for cocaine use at 9 weeks. Started Apr 2007; status: completed.
02
Drugs
vigabatrin
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00527683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527683.